Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(S)-2-((2S,5S,8S,11S,14S,20S,23S,26S,29S,32S,38S)-11-((1H-imidazol-5-yl)methyl)-38-amino-26-benzyl-8,32-bis(3-guanidinopropyl)-23-(hydroxymethyl)-39-(1H-indol-3-yl)-5-isobutyl-14-isopropyl-2,20,29-trimethyl-4,7,10,13,16,19,22,25,28,31,34,37-dodecaoxo-3,6,9,12,15,18,21,24,27,30,33,36-dodecaazanonatriacontanamido)-N1-(2-(2-((S)-4-amino-1-(2-amino-2-oxoethylamino)-1,4-dioxobutan-2-ylamino)-2-oxoethylamino)-2-oxoethyl)succinamide
ID: ALA4785281
Chembl Id: CHEMBL4785281
PubChem CID: 162665821
Max Phase: Preclinical
Molecular Formula: C79H120N30O21
Molecular Weight: 1826.02
Molecule Type: Unknown
Associated Items: